PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients

NCT04711434 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
260
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Sun Yat-sen University

Collaborators